Journal
MOLECULES
Volume 25, Issue 24, Pages -Publisher
MDPI
DOI: 10.3390/molecules25246052
Keywords
Morella; Myrica; myricanol; myricitrin; in vitro; in vivo
Funding
- FCT-Fundacao para a Ciencia e a Tecnologia [SFRH/BD/144446/2019]
- FCT-Fundacao para a Ciencia e Tecnologia
- European Union
- QREN
- FEDER
- COMPETE, through cE3c center [UIDB/00329/2020]
- COMPETE, through LAQV-REQUIMTE [UIDB/50006/2020]
- Spanish MINECO project [RTI2018-094356-B-C21]
- European Regional Development Fund (FEDER)
- Fundação para a Ciência e a Tecnologia [SFRH/BD/144446/2019] Funding Source: FCT
Ask authors/readers for more resources
Terrestrial plants, due to their sessile nature, are highly exposed to environmental pressure and therefore need to produce very effective molecules that enable them to survive all the threats. Myrica and Morella (Myricaceae) are taxonomically close genera, which include species of trees or shrubs with edible fruits that exhibit relevant uses in traditional medicine. For instance, in Chinese or Japanese folk medicine, they are used to treat diarrhea, digestive problems, headache, burns, and skin diseases. A wide array of compounds isolated from different parts of Myrica and/or Morella species possess several biological activities, like anticancer, antidiabetic, anti-obesity, and cardio-/neuro-/hepatoprotective activities, both in vitro and in vivo, with myricanol, myricitrin, quercitrin, and betulin being the most promising. There are still many other compounds isolated from both genera whose biological activities have not been evaluated, which represents an excellent opportunity to discover new applications for those compounds and valorize Morella/Myrica species.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available